Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05395403
Other study ID # IRB-300006396
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 5, 2021
Est. completion date July 5, 2021

Study information

Verified date May 2022
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three visits for patients (N=28) referred to a specialty hypertension (HTN) clinic. Demographic data were analyzed using summary statistics. The differences between AOBPM, HBPM, and OBPM were examined using mixed models repeated measures analysis for time and method for each visit.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date July 5, 2021
Est. primary completion date July 5, 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - 19 years and older - Uncontrolled BP - Prescribed three or more antihypertensive medications at the time of referral - Higher risk for poor CV outcomes than patients with essential HTN - OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment. Exclusion Criteria: - Less than 19 years old - Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment. - Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Blood pressure measurement device
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham Troy University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants using Traditional office blood pressure measurement (OBPM) Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg Baseline
Primary Number of participants using Traditional office blood pressure measurement (OBPM) Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg Up to 8 weeks
Primary Number of participants using Traditional office blood pressure measurement (OBPM) Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg Up to 16 weeks
Primary Number of participants using Automated office blood pressure measurement (AOBPM) Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg Baseline
Primary Number of participants using Automated office blood pressure measurement (AOBPM) Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg Up to 8 weeks
Primary Number of participants using Automated office blood pressure measurement (AOBPM) Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg Up to 16 weeks
Primary Number of participants using Home blood pressure measurement (HBPM) Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg Baseline
Primary Number of participants using Home blood pressure measurement (HBPM) Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg Up to 8 weeks
Primary Number of participants using Home blood pressure measurement (HBPM) Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg Up to 16 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A